Intellectus Partners, LLC Sorrento Therapeutics, Inc. Transaction History

Intellectus Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $1.12 Million - $2.36 Million	-557,026 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $3.79 Million - $6.38 Million	-797,422 Reduced 58.87%	557,026 $4.01 Million
Q1 2018 May 15, 2018	SELL	$4.5 - $9.95 $801,000 - $1.77 Million	-178,000 Reduced 11.62%	1,354,448 $6.98 Million
Q4 2017 Feb 13, 2018	SELL	$1.75 - $3.8 $16,532 - $35,898	-9,447 Reduced 0.61%	1,532,448 $5.82 Million
Q3 2017 Nov 14, 2017	SELL	$1.63 - $2.0 $71,630 - $87,890	-43,945 Reduced 2.77%	1,541,895 $2.62 Million
Q2 2017 Aug 15, 2017	BUY	N/A	1,585,840	1,585,840 $3.17 Million

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.